Efficacy analysis of intravenous moxifloxacin in the treatment of community acquired pneumonia in adults patients

Objective To observe the efficacy and safety of Moxifloxacin in the treatment of community-acquired pneumonia(CAP) in the adults patients.Methods 60 patients with CAP were randomly divided into treatment group and control group(n=30 in each).The treatment group was treated with Moxifloxacin,and the control group was treated with Levofloxacin,both groups were treated for 1 to 2 weeks.The clinical effect,bacterial clearance rate and adverse events were observed.Results The effective rate of the treatment group and control group were 86.7% and 70.0%.The bacterial clearance rate in the two groups were 96.2% and 88.9% respectively,and the difference was statistically significant(P0.05).There were no severe drug-related adverse events in the two groups.Conclusion Moxifloxacin in the treatment of CAP in the adults patients is safe and effective,and worthy in clinical application.